U.S. Interactive Media and Services Stock News

How CSX Stock Has Been Performing Recently CSX (CSX) has drawn investor attention after a period of mixed short term returns, with the stock roughly flat over the past day, lower over the past week, yet positive over the past month and past 3 months. See our latest analysis for CSX. At a share price of US$46.16, CSX has seen short term share price momentum ease slightly. However, the 90 day share price return of 16.65% and 1 year total shareholder return of 44.13% point to stronger...

Earlier in 2026, Barclays reaffirmed its positive rating on Kinder Morgan after the company reported strong quarterly results and a US$10.10 billion project backlog that now includes several data center-related contracts. An interesting angle for investors is how this enlarged backlog, combined with expectations for higher adjusted earnings and EBITDA, reinforces Kinder Morgan’s case for durable, contract-based cash flows and ongoing dividend support. We’ll now examine how Kinder Morgan’s...

HF Sinclair was recently upgraded to a Zacks Rank #2 (Buy) on the back of higher earnings estimates, and in July 2026 it released its Q2 2026 results alongside a webcast discussing performance across its refining and global lubricants operations. The analyst upgrade, rooted in improving earnings expectations, highlights how changes in forecast profitability can meaningfully influence how investors view HF Sinclair’s future prospects. Next, we’ll examine how the Zacks earnings-driven upgrade...

Southern Copper (SCCO) is back in focus after the company said it exceeded its 2026 copper production targets and outlined a decade-long expansion program in Peru and Mexico totaling more than US$20.5 billion. See our latest analysis for Southern Copper. The share price has pulled back recently, with a 1-day share price return of 5.97% and a 7-day share price return of 8.20%. However, the year to date share price return of 22.33% and 1-year total shareholder return of 95.99% point to strong...

With the US Federal Reserve under Kevin Warsh signaling a more hawkish stance and bond yields reacting, short term US Treasury and government bond ETFs are back in focus for investors weighing risk and income. As markets adjust to the prospect of rate hikes and a smaller, less interventionist central bank, some stocks exposed to this news may appear better positioned than others. This article walks through three positively exposed stocks from the Short-Term US Treasury and Government Bond...

Aeluma stock: recent moves in context Aeluma (ALMU) shares have seen mixed recent performance, with the stock down 6.4% on the day and 7.5% over the past week, while still up over the past 3 months and year to date. For investors tracking shorter term swings alongside longer term performance, these moves raise questions about how current pricing lines up with Aeluma’s revenue of US$5.196 million and its reported net loss of US$6.004 million. See our latest analysis for Aeluma. At a share...

In late May, Intuitive Surgical announced that long-time executive Taylor Patton would become Chief Commercial and Marketing Officer from July 1, while former CCMO Henry Charlton moved to a new Senior Vice President of Global Business Operations role to support value generation and continuity. These leadership shifts occurred as the company managed FDA safety alerts, product recalls, and rising competition in robotic-assisted surgery, putting its recurring revenue model and installed base...

Eli Lilly (NYSE:LLY) has entered a new multi-target research and license agreement with Abbisko Therapeutics. The partnership focuses on early-stage discovery programs and access to new therapeutic targets. The deal includes multiple potential drug candidates and substantial milestone opportunities. Eli Lilly is expanding its reach in biopharmaceutical research through this agreement with Abbisko, adding more early-stage programs to its pipeline. For you as an investor, this points to a...

Murphy Oil Corporation recently reported an oil discovery at the Bubale-1X exploration well in Block CI-709 offshore Côte d’Ivoire, where the late-February-spud well encountered 100 feet of net oil pay across two reservoirs containing high-quality light oil. The find, made with Murphy holding a 90% working interest alongside state oil company PETROCI, closes its current three-well campaign and moves the block into an appraisal phase that could materially influence future development plans...

Dauch (DCH) has attracted investor attention after a period of share price weakness, with the stock down 8% over the past week and 12% over the past month from its recent close. See our latest analysis for Dauch. Looking beyond this recent weakness, Dauch’s 1-year total shareholder return of 35.89% contrasts with its year to date share price decline of 12.48%. This suggests momentum has cooled following a stronger prior period. If you want to see what else is moving around Dauch’s part of the...

Recent Performance Snapshot for UGI Stock UGI (UGI) has drawn attention after a mixed period for its stock, with the price recently closing at $34.72. Short term returns were positive, although the share price was down over the past month and over the past three months. See our latest analysis for UGI. Looking beyond the latest move, UGI stock shows short term share price momentum that has recently softened, with the year to date share price return down 7.73% while the 3 year total...

Lumentum Holdings (NasdaqGS:LITE) highlighted an AI-focused optics backlog exceeding $400 million at a recent global conference on AI ethics and governance. Leadership outlined how optical circuit switches and co packaged optics are positioned within AI data center infrastructure build outs. The company also discussed AI data center partnerships, emphasizing collaboration with large scale customers and ecosystem players. These comments add fresh detail on Lumentum Holdings' role in AI...

Yorkville America Equities LLC, sponsor and investment adviser for the Truth Social Funds, recently relaunched the Truth Social God Bless America ETF (ticker: YALL), which sits within Trump Media & Technology Group’s Truth.Fi fintech brand and continues to be managed by founder Adam Curran of Curran Financial Partners under an America-First investment thesis. This relaunch highlights Trump Media & Technology Group’s push to build out a broader financial products ecosystem tied to its Truth...

Hims & Hers Health (HIMS) is back in focus as investors weigh its expanding GLP-1 weight-loss offering, its new partnership with Novo Nordisk, and the international acquisition of Eucalyptus. See our latest analysis for Hims & Hers Health. Hims & Hers Health shares trade at US$32.96 after a strong recent run, with a 30 day share price return of 38.78% and a 90 day share price return of 58.16%, while the 1 year total shareholder return is down 23.26% but the 3 year total shareholder return is...

FedEx reported its fiscal fourth-quarter and full-year 2026 results, with Q4 revenue rising to US$25,007 million while net income slipped to US$1,598 million, and full-year revenue increasing to US$94,720 million alongside higher annual earnings per share from continuing operations of US$18.55. The company also completed the spin-off of FedEx Freight, raised its annual dividend by 5%, and issued new guidance calling for around 11% revenue growth and diluted EPS of US$16.55 to US$17.75 for...

On 23 June 2026, TD Cowen analyst Kyle Boucher reiterated a positive view on Bio-Techne, describing it as a premier small to mid-cap option despite ongoing life sciences market softness and recent insider selling. His comments, alongside a broader consensus that still sees moderate upside for the company despite funding and demand headwinds, suggest investors are reassessing how Bio-Techne is valued within a challenged sector. Next, we'll examine how this renewed analyst confidence, despite...

BridgeBio Pharma stock performance snapshot BridgeBio Pharma (BBIO) trades at $68.63 after a mixed recent performance, with gains over the past week but declines over the month and past 3 months, while its 1 year total return remains positive. Investors watching BridgeBio Pharma may also note annual revenue of $579.96 million alongside a reported net loss of $721.55 million. This highlights an active development pipeline that is not yet translating into positive earnings. See our latest...

Infleqtion stock moves after recent performance swing Infleqtion (INFQ) has drawn attention after a sharp move in its stock, with a 12.3% gain over the past day and a 19.3% rise across the past week prompting closer investor scrutiny. See our latest analysis for Infleqtion. Set against a year-to-date share price return that is down 6.9%, the recent 40.9% 90-day share price return suggests momentum in Infleqtion is building again as investors reassess its quantum computing potential and risk...

F.N.B (FNB) has drawn investor attention after recent share price moves, with the stock closing at US$18.75. That puts the regional bank's market value at around US$6.5b. See our latest analysis for F.N.B. Recent trading has added to a relatively steady upswing for F.N.B, with a 1 day share price return of 2.12% and a 90 day share price return of 13.71%, alongside a 1 year total shareholder return of 34.32% that points to momentum building over a longer horizon. If F.N.B has you looking more...

In recent weeks, Marriott International has rolled out its Ask Bonvoy conversational AI search in beta, opened its 10,000th property, the JW Marriott Ranthambore Resort & Spa in India, and entered a joint venture to bring luxury wellness brand Lefay into its global portfolio. These moves highlight how Marriott is pairing large-scale global expansion with proprietary AI, wellness, and lifestyle offerings to deepen loyalty and differentiate its hotel network. We’ll now examine how the Ask...

At its Pure//Accelerate 2026 event earlier this month, Veeam Software and Everpure expanded their global alliance and unveiled new integrated cyber resilience, DataAI Resilience, and Kubernetes protection capabilities across Everpure’s Enterprise Data Cloud and Portworx stack. Together with Everpure’s new Data Stream and Data Intelligence offerings, these moves push the company further toward a data-centric AI infrastructure role that tightly couples storage, governance, and cyber resilience...

Earlier this week, US auto safety regulators opened a special investigation into a fatal Tesla Model 3 crash in Texas where the driver reported using the car’s automated driving assistance system, intensifying scrutiny of Tesla’s Autopilot and Full Self-Driving technologies. The probe directly targets systems that underpin Tesla’s autonomy and robotaxi ambitions, a core pillar of the company’s high-margin software-led business thesis. We’ll now examine how this new federal safety...

Earlier in June 2026, CoStar Group launched Apartments.com Ai, an AI-powered, conversational apartment search experience built on its proprietary multifamily data to help renters discover, compare and lease apartments through natural language interactions. This rollout extends CoStar’s broader push into AI-enabled real estate tools, signaling an effort to differentiate its rental platforms through deeply personalized, data-rich guidance across the entire renter journey. We’ll now examine how...

MoonLake Immunotherapeutics (MLTX) has become a focus for many investors after strong one-year Phase 3 VELA data for sonelokimab in hidradenitis suppurativa and a planned Biologics License Application filing by the end of September. See our latest analysis for MoonLake Immunotherapeutics. That clinical update has come alongside a sharp move in MoonLake Immunotherapeutics’ share price, with a 7-day share price return of 11.80% and a 30-day share price return of 16.66%. However, the 1-year...